Intestinal secretory antibody response induced by an oral cholera vaccine in human volunteers. 1988

A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
Laboratory of Immunology, INSERM U80 UA 1177 UCBL, Hôpital E. Herriot, Lyon, France.

The ability is reported of a new oral cholera vaccine composed of Vibrio cholerae antigenic fractions to induce a serum and mucosal antibody response after three oral administrations of microgranules to 18 French volunteers according to different protocols of immunization. Specific antibodies were detected in the three different fluids studied (saliva, jejunal fluid, serum) in one third of volunteers before vaccination. An increase of specific IgA antibody level was observed in jejunal fluids of most volunteers after oral vaccination. An augmentation of specific antibodies against vaccine antigenic components was also observed in serum and in saliva after vaccination but in fewer volunteers.

UI MeSH Term Description Entries
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
October 2023, Vaccine,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
January 1976, Developments in biological standardization,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
January 1975, Bulletin of the World Health Organization,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
January 1975, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
May 2014, The New England journal of medicine,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
September 1988, The Southeast Asian journal of tropical medicine and public health,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
March 1993, The Southeast Asian journal of tropical medicine and public health,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
June 1989, The Southeast Asian journal of tropical medicine and public health,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
September 1993, Infection and immunity,
A Langevin-Perriat, and S Lafont, and C Vincent, and J P Revillard, and M C Mazert, and G Gerfaux, and F Tron
January 1993, Vaccine,
Copied contents to your clipboard!